Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Grace A Kanzawa-Lee"'
Autor:
Ellen M. Lavoie Smith, PhD, Clare Kuisell, PhD, Youmin Cho, MSN, Grace A. Kanzawa-Lee, PhD, Laura S. Gilchrist, PhD, Susanna B. Park, PhD, Mary R Scott, MSN, Paola Alberti, MD, PhD
Publikováno v:
Cancer Treatment and Research Communications, Vol 28, Iss , Pp 100420- (2021)
Abstract/Summary: This systematic review provides a high-quality synthesis of the empirical evidence regarding chemotherapy-induced peripheral neuropathy (CIPN) characteristics and patterns described in studies of children who received neurotoxic che
Externí odkaz:
https://doaj.org/article/e40e62d374694ce7a61f47a411c2c6f7
Autor:
Robert Ploutz-Snyder, Ellen M. Lavoie Smith, Ken Resnicow, John C. Krauss, Janet L. Larson, Grace A Kanzawa-Lee
Publikováno v:
Cancer Nursing. 45:E531-E544
Background Oxaliplatin-induced peripheral neuropathy (OIPN) is prevalent among gastrointestinal cancer survivors and often impairs quality of life (QOL). Objective This pilot randomized controlled trial aimed to explore the effect of an 8-week home-b
Autor:
Grace A Kanzawa-Lee
Publikováno v:
Journal of Infusion Nursing. 43:155-166
Chemotherapy-induced peripheral neuropathy (CIPN) is an unsolved and potentially life-compromising problem for most patients receiving neurotoxic chemotherapy. It manifests with numbness, tingling, and possibly neuropathic pain and motor and autonomi
Publikováno v:
Cancer Nursing. 43:E172-E185
Background No effective cures for chemotherapy-induced peripheral neuropathy (CIPN) are known; however, exercise may be beneficial. Objective The purpose of this review was to synthesize high-quality research publications reporting the effects of exe
Autor:
Grace A, Kanzawa-Lee, Robert J, Ploutz-Snyder, Janet L, Larson, John C, Krauss, Kenneth, Resnicow, Ellen M, Lavoie Smith
Publikováno v:
Cancer nursing. 45(2)
Oxaliplatin-induced peripheral neuropathy (OIPN) is prevalent among gastrointestinal cancer survivors and often impairs quality of life (QOL).This pilot randomized controlled trial aimed to explore the effect of an 8-week home-based brisk walking (th
Publikováno v:
Semin Oncol Nurs
Objective To describe the known predictors and pathophysiological mechanisms of chronic painful chemotherapy-induced peripheral neuropathy (CIPN) in cancer survivors and the challenges in assessing and managing it. Data Sources PubMed/Medline, CINAHL
Publikováno v:
Asia-Pacific Journal of Oncology Nursing, Vol 6, Iss 4, Pp 318-332 (2019)
Asia-Pacific Journal of Oncology Nursing
Asia-Pacific Journal of Oncology Nursing
Objective: The recent American Society of Clinical Oncology (ASCO) Clinical Guidelines for chemotherapy-induced peripheral neuropathy (CIPN) management (48 Phase III trials reviewed) only recommend duloxetine. However, before concluding that a CIPN i
Autor:
Ellen M. Lavoie Smith, Grace A Kanzawa-Lee, Youmin Cho, Jamie L. Renbarger, Jenna Swets, Laura Gilchrist, Celia M. Bridges, Clare Kuisell
Publikováno v:
J Pediatr Oncol Nurs
Background: Chemotherapy-induced peripheral neuropathy (CIPN) is commonly experienced by children receiving neurotoxic chemotherapy. No validated pediatric CIPN patient-reported outcome (PRO) measures exist. Purpose: To test sensitivity, internal con
Publikováno v:
Cancer nursing. 43(3)
No effective cures for chemotherapy-induced peripheral neuropathy (CIPN) are known; however, exercise may be beneficial.The purpose of this review was to synthesize high-quality research publications reporting the effects of exercise on CIPN and rela
Autor:
Ellen M. Lavoie Smith, Charles L. Loprinzi, Jennifer Le-Rademacher, Celia M. Bridges, James J. Yang, Grace A Kanzawa-Lee, Noah R. Zanville, Clare Donohoe
Publikováno v:
Supportive Care in Cancer. 27:2599-2608
PURPOSE: To test the psychometric properties of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire–Chemotherapy-Induced Peripheral Neuropathy (QLQ-CIPN20) using Rasch-based methods. METHODS: A secon